Evidence map›Paper›PMID 33127195›Full record

ArticleJournal of substance abuse treatment2021

A commentary on the impact of COVID-19 on engagement of youth with substance use and co-occurring psychiatric disorders.

Sarah M Bagley, Scott E Hadland, Amy M Yule

Open access · bronzeAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sarah M BagleyDivision of General Pediatrics, Department of Pediatrics, Boston University School of Medicine, 801 Albany Street, Room 2055, Boston, MA, 02119, United States of America; Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, 801 Massachusetts Avenue, 2(nd) Floor, Boston, MA 02118, United States of America; Grayken Center for Addiction, Boston Medical Center, Boston, MA. Electronic address: sarah.bagley@bmc.org.
Scott E HadlandDivision of General Pediatrics, Department of Pediatrics, Boston University School of Medicine, 801 Albany Street, Room 2055, Boston, MA, 02119, United States of America; Grayken Center for Addiction, Boston Medical Center, Boston, MA.
Amy M YuleGrayken Center for Addiction, Boston Medical Center, Boston, MA.
Boston Medical Center · US

Funding

AACAP Physician Scientist Program in Substance UseK12DA000357 · NIDA · AMERICAN ACADEMY-CHILD/ADOLESCENT PSYCH · PI Kevin M. Gray · 1998 to 2026
$29.1M
Collaborative Care Office-Based Opioid Treatment for Adolescents and Young AdultsK23DA045085 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI HADLAND, SCOTT EVAN · 2018 to 2022
$1.1M
A Behavioral Intervention to Engage Emerging Adults in Addiction Treatment after a Non-fatal Opioid OverdoseK23DA044324 · NIDA · BOSTON MEDICAL CENTER · PI BAGLEY, SARAH M · 2017 to 2021
$938k
NIDA NIH HHS K12 DA000357NIDA NIH HHS K23 DA044324NIDA NIH HHS K23 DA045085NIDA NIH HHS L40 DA042434
6 · The paper itself

Abstract

Adolescents and young adults (AYA) with substance use disorders (SUD) have low rates of engagement and retention in SUD treatment (Mericle et al., 2015). Engagement and retention refers to treatment attendance and regular communication with providers. The reason for this low rate is multifactorial and includes the stigma surrounding SUD and treatment (Bagley, Hadland, Carney, & Saitz, 2017), and challenges accessing developmentally appropriate treatment (Mericle et al., 2015; Sterling, Weisner, Hinman, & Parthasarathy, 2010). Yet engaging AYA early in their trajectory of substance use offers an invaluable opportunity to minimize the short-term and long-term consequences of use (Compton et al., 2019; Levy, Williams, & Prevention, C. on S. U. A., 2016). As specialists in pediatric addiction, we made significant changes in how we provide care for youth in treatment due to the COVID-19 pandemic. In the following commentary, we discuss the potential positive and negative impacts of those changes and suggestions for future research.

Indexed as

ComorbidityTelemedicineAdolescentHumansMental DisordersPediatricsSubstance-Related DisordersYoung AdultAdolescents and young adultsCOVID-19Substance use disorderTelemedicineYouth

Identifiers

PMID33127195
PMCPMC7575435
OpenAlexW3093594770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.